Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-02-28 @ 8:47 PM
Study NCT ID:
NCT02155660
Status:
COMPLETED
Last Update Posted:
2019-06-26
First Post:
2014-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-20
First Submit QC Date:
None
Study First Post Date:
2014-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-18
Results First Submit QC Date:
None
Results First Post Date:
2019-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-07
Last Update Post Date:
2019-06-26
Last Update Post Date Type:
ACTUAL